share_log

HC Wainwright & Co. Reiterates Neutral on Atara Biotherapeutics

Benzinga ·  May 22 07:07

HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment